Study of the Cabochon System for Improvement in the Appearance of Cellulite

Exclusion Criteria

• •cellulite treatment on the thighs or buttocks in the last 90 days
• •prior liposuction in the thighs or buttocks
• •Greater than 10% increase or decrease in body weight within past 6 months
• •evidence of active infection or a fever \>38C
• •current or recent smoker
• •history of hypertension, diabetes or hypoglycemia
• •history of coagulopathy(ies) and/or on anticoagulant medication
• •history of cardiopathy or pneumopathy
• •history of severe anemia
• •has atrophic scars, or has a history of atrophic scars or keloids
• •taken within 14 days of treatment:
• •* NSAIDs (e.g. aspirin, ibuprofen, naproxen)
• •* Vitamin E, dietary supplements (e.g. Gingko Biloba, willow bark)
• •* Herbal Teas
• •Subject is pregnant or lactating
• •For Extended Follow-Up the following apply:
• •Subject has undergone an injected drug, energy-based device, minimally-invasive or invasive procedure for contouring or cellulite on the buttocks or thighs since their 12 month study follow-up visit.
• •Subject has used skin care products (e.g. creams) for improvement in cellulite within 1 month prior to the follow-up visit.